Recruiting
Rasmussen encephalitis
RecruitingInvestigationalNo placebo
Study on the Safety of Repeated Intra-Arterial Infusion of Mesenchymal Stem Cells for Children and Adolescents with Refractory Epilepsy
InvestigationalNo placebo
- Disease:Rasmussen encephalitis
- Substances:Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
Countries:
Spain
Spain- Participants:0–17 years
- Substances:Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Transduced With Icovir-5, Ex Vivo Expanded
- Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa
